Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Caenorhabditis Elegans
100%
Anti-infective Drugs
100%
Preclinical Drug Discovery
100%
Drug Discovery Screening
100%
Anti-infective
42%
Knockdown
14%
Antimicrobial
14%
Drug Discovery
14%
High-throughput Screening
14%
Human Health
14%
Screening Method
14%
Small Molecules
14%
Expert Opinion
14%
Area Cover
14%
Mode of Action
14%
Promising Solutions
14%
Screening Strategy
14%
Clinically Approved Drugs
14%
Host Gene
14%
Antibiotic Resistant
14%
Effective Antibiotics
14%
Bioactive Compounds
14%
Immunomodulator
14%
Hit Compound
14%
Bacterial Genes
14%
Novel Antibiotics
14%
In Vitro Screens
14%
Antivirulence
14%
Tolerant Bacteria
14%
Secondary Study
14%
Conventional Antimicrobials
14%
Chemistry
Antiinfective
100%
Drug Discovery
100%
Pool
25%
Non Toxic
25%
High Throughput Screening
25%
Antivirulence
25%
Immunomodulator
25%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
100%
Caenorhabditis elegans
100%
Antibiotics
28%
Infection
14%
High-Throughput Screening
14%
Antiinfective Agent
14%
Immunomodulating Agent
14%
Biochemistry, Genetics and Molecular Biology
Caenorhabditis elegans
100%
Drug Development
100%
Genetics
14%
Solution and Solubility
14%
High Throughput Screening
14%
Small Molecule
14%
Bacterial Gene
14%
Medicine and Dentistry
Caenorhabditis elegans
100%
Antibiotics
28%
Infection
14%
In Vitro
14%
Antiinfective Agent
14%
Public Health
14%
High Throughput Screening
14%
Immunomodulating Agent
14%
Bacterial Gene
14%
Immunology and Microbiology
Caenorhabditis elegans
100%
Solution and Solubility
14%
High Throughput Screening
14%
Bacterial Gene
14%
Immunomodulating Drug
14%
Infection
14%
In Vitro
14%